All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

The type 1 ryanodine receptor (RyR1) is a Ca^2+^ release channel in the sarcoplasmic reticulum (SR) of skeletal muscle and plays an important role in excitation--contraction (E-C) coupling \[[@pone.0130606.ref001], [@pone.0130606.ref002]\]. RyR1 is a homotetramer of large (\>5,000 residues) subunits. Most parts of the amino (N)-terminal cytoplasmic domain constitute the \"foot\" structure, which spans the junctional gap between the SR and transverse (T)-tubule, whereas a small carboxyl (C)-terminal domain (≈500 residues) contains the transmembrane segments that form an ion-conducting pore \[[@pone.0130606.ref003]\]. RyR1 is activated by a conformational change of the voltage sensor in the dihydropyridine receptor (DHPR) upon depolarization of the T-tubule membrane, which is referred to as the depolarization-induced Ca^2+^ release (DICR) \[[@pone.0130606.ref004], [@pone.0130606.ref005]\]. The channel is also activated by Ca^2+^, i.e., Ca^2+^-induced Ca^2+^ release (CICR) \[[@pone.0130606.ref006], [@pone.0130606.ref007]\], although the rate of Ca^2+^ release via CICR is reported to be much lower than that via DICR under physiological conditions \[[@pone.0130606.ref007], [@pone.0130606.ref008]\].

Mutations in RyR1 are associated with several muscle disorders, including malignant hyperthermia (MH) and central core disease (CCD) \[[@pone.0130606.ref009]\]. MH is an autosomal dominant and potentially lethal pharmacogenetic disorder in which the inhalation of volatile anesthetics (e.g., halothane) or muscle relaxants (e.g., succinylcholine) triggers high fever and muscle contracture, leading to death if untreated \[[@pone.0130606.ref010]\]. More than 150 different point mutations for MH have been identified in the RyR1 gene and the majority of mutations cluster in three \'hotspots\': N-terminal (35--614) and central (2129--2458) regions located in the cytoplasm, and carboxyl (C)-terminal region (4637--4973) near or within channel forming segments \[[@pone.0130606.ref011]\]. CCD is an autosomal dominant myopathy that is characterized by hypotonia at birth, mild delay in childhood development and skeletal malformations \[[@pone.0130606.ref012]\]. More than 60 mutations for CCD have been identified in the RyR1 gene and these mutations are also clustered in similar hotspots to the MH mutations \[[@pone.0130606.ref011]\]. CCD mutations in the N-terminal and central regions are susceptible to MH (i.e., MH/CCD mutations) \[[@pone.0130606.ref009]\]. The underlying pathology of these mutations is an enhanced Ca^2+^ release activity of the RyR1 channel, i.e., gain-of-function phenotype. In MH patients, accelerated channel activation leads to increased sensitivity to drugs (halothane or succinylcholine). In MH/CCD patients, the accelerated channel activity triggers uncompensated Ca^2+^ leakage from the SR under resting conditions \[[@pone.0130606.ref013]--[@pone.0130606.ref015]\]. Some CCD mutations in the C-terminal region, in contrast, cause loss-of-function phenotype, in which Ca^2+^ release triggered by depolarization is strongly suppressed (E-C uncoupling) \[[@pone.0130606.ref016]--[@pone.0130606.ref018]\]. These CCD mutations appear to be insusceptible to MH.

RyR1 exhibits biphasic bell-shaped Ca^2+^ dependence in CICR \[[@pone.0130606.ref006], [@pone.0130606.ref007]\]. This is explained by the action of two distinct Ca^2+^ sites: binding of Ca^2+^ to a high-affinity site (A-site) activates the channel, whereas binding of Ca^2+^ to a low-affinity site (I-site) inactivates the channel. Ca^2+^ sensitivities of A- and I-sites are important parameters for the activity of the RyR1 channel. In addition, a third parameter, i.e., gain, sets the maximal attainable activity independent of Ca^2+^ sensitivities \[[@pone.0130606.ref008], [@pone.0130606.ref019]\]. The three parameters define the activity profiles of the RyR1 channel. However, it remains unclear how disease-associated mutations affect the activity profiles and which parameter(s) of the activity profiles is important for different phenotypes, i.e., MH and MH/CCD.

In this study, we investigated 11 mutations at 7 different positions in the amino (N)-terminal region of RyR1 (9 MH and 2 MH/CCD mutations) using a heterologous expression system in HEK293 cells. The disease-associated mutations divergently altered the activity profiles in a site-specific manner by increasing the gain and the sensitivity to activating Ca^2+^. Our results provide a reasonable explanation for the mechanisms of MH and MH/CCD phenotypes caused by specific mutations in the N-terminal region of the RyR1 channel.

Materials and Methods {#sec002}
=====================

Construction of the expression plasmids {#sec003}
---------------------------------------

cDNA cassettes encoding the full-length rabbit skeletal muscle RyR1 (pBS-RyR1) were used for mutagenesis \[[@pone.0130606.ref020]\]. Each disease-associated mutation in the N-terminal region corresponding to C36R, R164C, R164L, G249R, G342R, R402C, R402H, Y523C, Y523S, R615C and R615L was introduced by inverse polymerase chain reaction (PCR) using a *Hind*III-*Sal*I fragment (pBS-RyR1cs1) or a *Sal*I-*Bsu*36I fragment (pBS-RyR1cs2) as the PCR template. The mutations were confirmed by DNA sequencing. Each mutated fragment was subcloned into the expression vector (pcDNA5/FRT/TO-RyR1) \[[@pone.0130606.ref021]\] using the appropriate restriction enzymes.

Generation of stable inducible HEK293 cell lines {#sec004}
------------------------------------------------

HEK293 cells stably and inducibly expressing RyR1 mutants were generated as described \[[@pone.0130606.ref021]\] using the Flp-In T-REx system (Life Technologies, CA, USA). Clones with suitable expression of RyR1 were selected and used for experiments.

Single-cell Ca^2+^ imaging {#sec005}
--------------------------

Ca^2+^ measurements were carried out in HEK293 cells expressing WT or mutant RyR1 grown on a glass bottom dish for 24--30 h after induction by doxycycline. Experiments were carried out at room temperature (RT; \~25°C) or 36°C using a temperature control system for glass bottom dishes (CL-100/SC29 and TC324C, Warner Instruments, CT, USA).

### Determination of caffeine responses with Fluo-4 {#sec006}

For determination of caffeine responses, HEK293 cells were loaded with 4 μM fluo-4 AM in culture medium for 30 min at 37°C in a CO~2~ incubator and then washed with HEPES buffered Krebs solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 11 mM glucose, 5 mM HEPES, pH 7.4). The dish was placed on the stage of an inverted microscope equipped with the Nipkow disc confocal system (CSU22, Yokogawa, Japan). Cells were treated initially with 10 mM caffeine to deplete Ca^2+^ and then equilibrated with normal Krebs solution for 5 min. The cells were then perfused with caffeine-containing (0.1--10 mM) Krebs solution, as described previously \[[@pone.0130606.ref021]\] and fluo-4 signals, excited at 488 nm and emitting at 525 nm, were captured with a electron-multiplying (EM)-CCD camera at 700 ms intervals (Model 8509, Hamamatsu Photonics, Hamamatsu, Japan). At the end of each experiment, a high Ca^2+^ Krebs solution containing 20 mM Ca^2+^ and 20 μM ionomycin was applied to obtain the maximal fluorescence intensity (*F* ~max~) of fluo-4 in individual cells. Average fluorescence intensities in individual cells were determined using region of interest (ROI) analysis with AquaCosmos software and normalized to the *F* ~max~.

### Resting cytoplasmic Ca^2+^ measurements with Fura-2 {#sec007}

For measurement of resting cytoplasmic Ca^2+^ (\[Ca^2+^\]~i~), cells were loaded at RT with 4 μM fura-2 AM for 30 min in a physiological salt solution (PSS) containing 150 mM NaCl, 4 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 5.6 mM glucose and 10 mM HEPES at pH 7.4. Cells were treated initially with 10 mM caffeine to deplete Ca^2+^ and then equilibrated in PSS for 10 min. Fluorescence images were acquired at \>420 nm using an inverted microscope equipped with a cooled CCD camera at a rate of one frame every 2 s. Excitation wavelengths were 345 nm and 380 nm. Ca^2+^ imaging experiments were conducted at RT. Image analysis was carried out using IPLab software (BD Biosciences Bioimaging, MD, USA). ROIs corresponding to individual cells were selected and the average fluorescence intensity (*F*) of each ROI minus the background intensity was calculated for each frame. We used the *F* ~345~/*F* ~380~ ratio (the value of *F* at an excitation wavelength of 345 nm divided by the value of *F* at an excitation wavelength of 380 nm) to estimate \[Ca^2+^\]~i~, as described previously \[[@pone.0130606.ref022]\]. The *K* ~D~ (239 nM) for Ca^2+^ was determined via an *in vitro* calibration of fura-2 fluorescence.

### Simultaneous recordings of ER and cytoplasmic Ca^2+^ {#sec008}

For simultaneous recording of ER and cytoplasmic Ca^2+^, cells were co-transfected with genetically-encoded Ca^2+^ indicators, G-GECO1.1 \[[@pone.0130606.ref023]\] for \[Ca^2+^\]~i~ and R-CEPIA1er \[[@pone.0130606.ref024]\] for ER Ca^2+^ (\[Ca^2+^\]~ER~). Doxycycline was added to the culture medium at the time of transfection. At 24--30 h after transfection, cells were washed with the HEPES-buffered Krebs solution and placed on the stage of the microscope. G-GECO1.1 and R-CEPIA1er were excited by 488 nm and 568 nm laser light, respectively, and fluorescence images at 525 and 620 nm were simultaneously captured, side-by-side on the same camera, using the W-view system (Hamamatsu Photonics, Hamamatsu, Japan). At the end of each experiment, the high Ca^2+^ Krebs solution was applied to obtain the *F* ~max~ of the Ca^2+^ indicators in individual cells. The fraction of the Ca^2+^-independent basal fluorescence signal was determined separately in the presence of 5 mM 1,2-bis(o-aminophenoxy)ethane-N,N,N\',N\'-tetraacetic acid (BAPTA) plus 20 μM ionomycin and subtracted from the total fluorescence signal. \[Ca^2+^\]~ER~ was calculated using parameters obtained by an *in situ* titration (*K* ~D~ = 455 nM, *n* = 1.59) \[[@pone.0130606.ref024]\].

\[^3^H\]Ryanodine binding assay {#sec009}
-------------------------------

HEK293 cells were cultured in five 150 mm dishes, and protein expression was induced with doxycycline (2 μg/ml) for 48 h. Microsomes were prepared by nitrogen cavitation \[[@pone.0130606.ref021]\]. The microsomes (50--100 μg of protein) were incubated with 5 nM \[^3^H\]ryanodine for 5 h at 25°C in a 100 μl solution containing 0.17 M NaCl, 20 mM 3-(*N*-morpholino)-2-hydroxypropanesulfonic acid (MOPSO), pH 6.8, 2 mM dithiothreitol, 1 mM AMP and various concentrations of free Ca^2+^ buffered with 10 mM ethylene glycol-bis(2-aminoethylether)-N,N,N\',N\'-tetraacetic acid (EGTA). For \[^3^H\]ryanodine binding experiments at 37°C, the incubation period was shortened to 3 h. Ca^2+^ concentrations were calculated using MaxChelator (<http://maxchelator.stanford.edu>) \[[@pone.0130606.ref025]\]. The protein-bound \[^3^H\]ryanodine was separated by filtering through polyethyleneimine-treated Whatman GF/B glass filters. Nonspecific binding was determined in the presence of 20 μM unlabeled ryanodine. The \[^3^H\]ryanodine binding data (*B*) were normalized by the maximum number of functional channels (*B* ~max~), which was separately determined by Scatchard plot analysis using varied concentrations (3--20 nM) of \[^3^H\]ryanodine in a high-salt buffer containing 1 M NaCl \[[@pone.0130606.ref008]\]. The resultant *B*/*B* ~max~ represents the averaged activity of each mutant.

Parameter analysis {#sec010}
------------------

To obtain the parameters of Ca^2+^-dependent \[^3^H\]ryanodine binding, the data were fitted to the following equation: $$A = A_{\text{max}} \times f_{\text{A}} \times \left( 1 - f_{\text{I}} \right)$$ where *A* is the activity at the specified Ca^2+^, *A* ~max~ is the gain that determines the maximal attainable activity, and *f* ~A~ and *f* ~I~ are fractions of the activating Ca^2+^ site (A-site) and inactivating Ca^2+^ site (I-site) occupied by Ca^2+^, respectively \[[@pone.0130606.ref008]\]. *f* ~A~ and *f* ~I~ at the specified Ca^2+^ concentration (\[Ca^2+^\]) are expressed as: $$f_{\text{A}} = \left\lbrack \text{Ca}^{2 +} \right\rbrack^{n_{\text{A}}}/\left( \left\lbrack \text{Ca}^{2 +} \right\rbrack^{n_{\text{A}}} + K_{\text{A}}{}^{n_{\text{A}}} \right)$$ $$f_{\text{I}} = \left\lbrack \text{Ca}^{2 +} \right\rbrack^{n_{\text{I}}}/\left( \left\lbrack \text{Ca}^{2 +} \right\rbrack^{n_{\text{I}}} + K_{\text{I}}{}^{n_{\text{I}}} \right)$$ where *K* ~A~ and *K* ~I~ are dissociation constants, and *n* ~A~ and *n* ~I~ are Hill coefficients for Ca^2+^ of A- and I-sites, respectively. From the shape of the Ca^2+^-dependent curves for WT and mutant channels, we assumed that the Hill coefficients are not largely dissimilar between the WT and mutant channels. We therefore used fixed values for *n* ~A~ (1.2) and *n* ~I~ (1.5) for WT and all the mutants at both 25 and 37°C. These values were chosen so as to maximize the sum of *R* ^2^ values for curve fitting of WT and all mutant channels. Curve fitting was performed using the Prism 6 software (GraphPad Software, CA, USA). The curves for *f* ~A~, 1--*f* ~I~, and *A* are shown in [S1 Fig](#pone.0130606.s001){ref-type="supplementary-material"}.

For estimation of ryanodine binding at resting \[Ca^2+^\]~i~, *A* at pCa 7 for each mutant was calculated by eqs [(1)](#pone.0130606.e001){ref-type="disp-formula"}--[(3)](#pone.0130606.e003){ref-type="disp-formula"} using the obtained parameters (*K* ~A~, *K* ~I~ and *A* ~max~).

Western blotting {#sec011}
----------------

Microsomal proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto a polyvinylidene fluoride membrane. Western blotting was performed using antibodies for RyR1 (34C, Developmental Studies Hybridoma Bank, University of Iowa, IA, USA) and calnexin (C4731, Sigma-Aldrich, MO, USA).

Data analysis {#sec012}
-------------

Data are presented as the means ± SE. Statistical comparisons have been made using the Prism 6 software. Student's t-test was used to compare two groups. *P* values \< 0.05 were considered significant.

Results {#sec013}
=======

Expression of RyR1 mutants {#sec014}
--------------------------

We chose 11 mutations at 7 different positions in the N-terminal region, one of the hotspots of disease-associated mutations \[[@pone.0130606.ref011]\] ([Table 1](#pone.0130606.t001){ref-type="table"}). Two different mutations were made at four positions (R164C/R164L, R402C/R402H, Y523C/Y523S and R615C/R615L). All mutations are susceptible to MH and two of them (R164C and Y523S) are also reported to show the CCD phenotype (i.e., MH/CCD) \[[@pone.0130606.ref009]\]. Six positions (C36, R164, G249, G342, R402 and Y523) map to the N-terminal region in the crystal structure and are localized to different domains/interfaces of the structure \[[@pone.0130606.ref026]\]. Functional characterizations using heterologous expression systems have been done for most mutations except for R402H and Y523C (see References in [Table 1](#pone.0130606.t001){ref-type="table"}). Among the 11 mutations, animal models exist for three mutations: R163C knock-in mice \[[@pone.0130606.ref027]\], Y524S knock-in mice \[[@pone.0130606.ref028]\] and MH pigs carrying R615C \[[@pone.0130606.ref029]\].
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###### Disease-associated mutations used in this study.

![](pone.0130606.t001){#pone.0130606.t001g}

  Residue[^a^](#t001fn001){ref-type="table-fn"}   Disease   Domain[^b^](#t001fn002){ref-type="table-fn"}   Interface[^b^](#t001fn002){ref-type="table-fn"}   Functional characterizationin expression system (Refs)
  ----------------------------------------------- --------- ---------------------------------------------- ------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  C36R                                            MH        A                                              A-B                                               \[[@pone.0130606.ref020], [@pone.0130606.ref031]\]
  R164C                                           MH/CCD    A                                              Interface 1, 4                                    \[[@pone.0130606.ref014], [@pone.0130606.ref020], [@pone.0130606.ref031], [@pone.0130606.ref044]--[@pone.0130606.ref046], [@pone.0130606.ref059]\]
  R164L                                           MH        A                                              Interface 1, 4                                    \[[@pone.0130606.ref042]\]
  G249R                                           MH        B                                              Buried                                            \[[@pone.0130606.ref020], [@pone.0130606.ref031], [@pone.0130606.ref059]\]
  G342R                                           MH        B                                              Interface 5                                       \[[@pone.0130606.ref020], [@pone.0130606.ref031], [@pone.0130606.ref044]\]
  R402C                                           MH        C                                              A-C                                               \[[@pone.0130606.ref054]\]
  R402H                                           MH        C                                              A-C                                               --
  Y523C                                           MH        C                                              interface 3                                       --
  Y523S                                           MH/CCD    C                                              interface 3                                       \[[@pone.0130606.ref014], [@pone.0130606.ref020], [@pone.0130606.ref030], [@pone.0130606.ref031]\]
  R615C                                           MH        --                                             --                                                \[[@pone.0130606.ref015], [@pone.0130606.ref020], [@pone.0130606.ref030], [@pone.0130606.ref031], [@pone.0130606.ref044], [@pone.0130606.ref045]\]
  R615L                                           MH        --                                             --                                                \[[@pone.0130606.ref020], [@pone.0130606.ref031]\]

^a^Residue numbers refer to rabbit RyR1.

^b^Domain and interface information is from the crystal structure of the RyR1 ABC domains \[[@pone.0130606.ref026]\].

Wild-type (WT) and mutant RyR1s were heterologously expressed in HEK293 cells using a tetracycline-inducible expression system \[[@pone.0130606.ref021]\]. The RyR1 mutants were expressed at similar levels to WT ([S2 Fig](#pone.0130606.s002){ref-type="supplementary-material"}).

Caffeine-induced Ca^2+^ transients {#sec015}
----------------------------------

To test the phenotypes of RyR1 with disease-associated mutations, we initially examined caffeine-induced Ca^2+^ transients in HEK293 cells at RT (25°C) ([Fig 1](#pone.0130606.g001){ref-type="fig"}). This assay is based on the observation that caffeine increases the sensitivity of RyR1 to activating Ca^2+^ \[[@pone.0130606.ref001], [@pone.0130606.ref002]\] and the EC~50~ for caffeine is a marker for detecting the MH phenotype. Typical fluo-4 Ca^2+^ signals are shown in [Fig 1A](#pone.0130606.g001){ref-type="fig"}. In WT, Ca^2+^ transients were detected at \~0.3 mM caffeine and reached a plateau at 3 mM or higher concentrations. Disease-associated mutants showed divergent responses. R164L produced Ca^2+^ transients at lower caffeine concentrations than WT with a reduced peak height. The MH/CCD phenotype Y523S exhibited very small Ca^2+^ transients. R615C showed enhanced caffeine sensitivity with a peak height comparable to WT. Dose-dependent plots of caffeine-induced Ca^2+^ transients revealed increased caffeine sensitivity and/or reduced peak amplitude in disease-associated mutations ([Fig 1B](#pone.0130606.g001){ref-type="fig"}). We determined the maximum Ca^2+^ transients ([Fig 1C](#pone.0130606.g001){ref-type="fig"}) and the EC~50~ for caffeine ([Fig 1D](#pone.0130606.g001){ref-type="fig"}) from the dose-dependent curves of each mutation. The peak Ca^2+^ transients were smaller and varied to a degree for some mutants (R164C, R164L, G342R, R402H, Y523C, Y523S and R615L) when compared with WT, but showed no change in other mutants (C36R, G249R, R402C and R615C). All the mutants except for C36R, Y523C and Y523S exhibited a significant reduction in the EC~50~ value.

![Caffeine-induced Ca^2+^ transients in cells expressing WT and mutant RyR1s.\
**A--D**. HEK293 cells expressing WT or mutant RyR1 channels were loaded with fluo-4 AM and stimulated by different concentrations (0.1--10 mM) of caffeine. Measurements were carried out at room temperature (RT). **A.** Representative traces of fluo-4 signals for WT and three mutants (R164L, Y523S and R615C). Caffeine was applied at the time points indicated by the short horizontal bars. Fluo-4 signals were normalized by *F* ~max~ (see [Materials and Methods](#sec002){ref-type="sec"}). **B.** The magnitude of the Ca^2+^ transients were plotted against caffeine concentrations and fitted to the dose-response curve. **C** and **D.** The maximum Ca^2+^ transients **(C)** and EC~50~ for caffeine **(D)** of WT (filled column), MH mutations (open columns) and MH/CCD mutations (hatched columns). Data are means ± SE (*n* = 78--150). **E.** HEK293 cells of WT (filled column), MH mutations (open columns) and MH/CCD mutations (hatched columns) were loaded with fura-2 AM and resting \[Ca^2+^\]~i~ was determined. Data are means ± SE (*n* = 207--494). **F.** The maximum caffeine-induced Ca^2+^ transients correlate well with resting \[Ca^2+^\]~i~. (*R* ^2^ = 0.76, dashed line).](pone.0130606.g001){#pone.0130606.g001}

We also noticed that the resting cytoplasmic Ca^2+^ (\[Ca^2+^\]~i~) level was higher in some disease-associated mutations than in WT (e.g., R164L and Y523S in [Fig 1A](#pone.0130606.g001){ref-type="fig"}). We quantitatively measured resting \[Ca^2+^\]~i~ using fura-2. Resting \[Ca^2+^\]~i~ was around 40 nM in cells expressing WT ([Fig 1E](#pone.0130606.g001){ref-type="fig"}). The disease-associated mutants, except for C36R and R615C, exhibited significantly higher resting \[Ca^2+^\]~i~, with values ranging between 50--90 nM. There was an inverse correlation between resting \[Ca^2+^\]~i~ and the maximum peak Ca^2+^ transients induced by caffeine (*R* ^2^ = 0.76) ([Fig 1F](#pone.0130606.g001){ref-type="fig"}).

Measurements of ER luminal Ca^2+^ {#sec016}
---------------------------------

The reduced peak value of caffeine-induced Ca^2+^ transients and corresponding increased resting \[Ca^2+^\]~i~ suggest a reduction of Ca^2+^ in the ER Ca^2+^ store (\[Ca^2+^\]~ER~). To test this possibility, we simultaneously measured \[Ca^2+^\]~i~ and \[Ca^2+^\]~ER~ in HEK293 cells ([Fig 2](#pone.0130606.g002){ref-type="fig"}). [Fig 2A](#pone.0130606.g002){ref-type="fig"} shows typical traces of \[Ca^2+^\]~i~ and \[Ca^2+^\]~ER~ signals. We initially treated the cells with 3 mM caffeine to deplete Ca^2+^ in the ER (open bars). After removal of the caffeine, \[Ca^2+^\]~ER~ gradually recovered and achieved a steady-state level. Resting \[Ca^2+^\]~ER~ was measured as *F*/*F* ~max~, in which fluorescence intensity of the steady-state level (*F*) was normalized by the maximum fluorescence intensity (*F* ~max~) of the indicator, which was determined by treating cells with high Ca^2+^ plus ionomycin at the end of experiments (filled bars). R164L and Y523S showed markedly lower \[Ca^2+^\]~ER~ than WT, whereas R615C exhibited a \[Ca^2+^\]~ER~ level similar to that of WT ([Fig 2A](#pone.0130606.g002){ref-type="fig"}). The *F*/*F* ~max~ values were converted to Ca^2+^ concentrations using parameters obtained in the *in situ* titration \[[@pone.0130606.ref024]\] and are summarized in [Fig 2B](#pone.0130606.g002){ref-type="fig"}. Two MH/CCD mutations, R164C and Y523S, exhibited severe depletion of \[Ca^2+^\]~ER~, which is consistent with previous reports \[[@pone.0130606.ref014], [@pone.0130606.ref015], [@pone.0130606.ref030], [@pone.0130606.ref031]\]. The other mutations, except for C36R, also showed significant reduction in \[Ca^2+^\]~ER~. The \[Ca^2+^\]~ER~ strongly correlated with the peak value of caffeine-induced Ca^2+^ transients (*R* ^2^ = 0.79) ([Fig 2C](#pone.0130606.g002){ref-type="fig"}) and resting \[Ca^2+^\]~i~ (*R* ^2^ = 0.82) ([Fig 2D](#pone.0130606.g002){ref-type="fig"}), indicating that small peak values of caffeine-induced Ca^2+^ transients are due to low \[Ca^2+^\]~ER~ levels.

![Determination of resting \[Ca^2+^\]~ER~ in cells expressing WT or mutant RyR1s.\
HEK293 cells expressing WT or mutant RyR1 channels were transfected with G-GECO1.1 and R-CEPIA1er to determine \[Ca^2+^\]~i~ and \[Ca^2+^\]~ER~, respectively. Measurements were carried out at RT. **A.** Typical traces for \[Ca^2+^\]~i~ (upper) and \[Ca^2+^\]~ER~ (lower) signals. Caffeine was initially applied to deplete Ca^2+^ in the ER (white bars) and then Ca^2+^ in the ER was determined at the plateau after the removal of caffeine. Finally, *F* ~max~ for indicators was determined by the application of 20 μM ionomycin and 20 mM Ca^2+^ (black bars). **B.** \[Ca^2+^\]~ER~ of WT (filled column), MH mutations (open columns) and MH/CCD mutations (hatched columns). Data are means ± SE (*n* = 35--99). \**p* \< 0.05 compared with WT. **C** and **D.** Peak caffeine-induced Ca^2+^ transients **(C)** and resting \[Ca^2+^\]~i~ **(D)** of WT (filled circle), MH mutations (open circles) and MH/CCD mutations (crosses) were plotted against \[Ca^2+^\]~ER~. Note that the peak caffeine-induced Ca^2+^ transients (*R* ^2^ = 0.79) and resting \[Ca^2+^\]~i~ (*R* ^2^ = 0.82) correlated strongly with \[Ca^2+^\]~ER~ (dashed lines).](pone.0130606.g002){#pone.0130606.g002}

It has been reported that caffeine or halothane induces Ca^2+^ oscillations in HEK cells expressing WT RyR1 and that a MH-associated mutation (R615C) reduced a threshold level of luminal Ca^2+^ for the spontaneous Ca^2+^ release, which is referred to as store-overload-induced Ca^2+^ release (SOICR) level \[[@pone.0130606.ref032]\]. We therefore tested whether this is also the case with the other disease-associated mutations by determining \[Ca^2+^\]~ER~ ([Fig 3](#pone.0130606.g003){ref-type="fig"}). Unlike RyR2 expressing cells, no Ca^2+^ oscillations were detected in WT nor any mutant RyR1 cells during 8-min observations in the absence of caffeine. In the presence of low concentration of caffeine, Ca^2+^ oscillations were detected in WT cells (9 out of 42 cells) ([Fig 3A](#pone.0130606.g003){ref-type="fig"}). R615C also exhibited Ca^2+^ oscillations (16 out of 36 cells) with higher frequency than that of WT ([Fig 3B](#pone.0130606.g003){ref-type="fig"}). These results are in agreement with the previous report \[[@pone.0130606.ref032]\].

![Caffeine-induced Ca^2+^ oscillations by monitoring ER Ca^2+^.\
ER Ca^2+^ of HEK293 cells expressing WT or mutant RyR1 channels (C36R, G249R and R615C) was monitored with R-CEPIA1er as described in [Fig 2](#pone.0130606.g002){ref-type="fig"}. **A.** Typical traces for ER Ca^2+^ signals. Cells were incubated for 2 min with normal Krebs solution containing 2 mM Ca^2+^ and 2 mM caffeine (grey bar). Ca^2+^ in Krebs solution was then increased to 5 mM (black bars). After depletion of Ca^2+^ by 30 mM caffeine, *F* ~max~ for indicators was determined by the application of 20 μM ionomycin and 20 mM Ca^2+^. **B.** Ca^2+^ oscillation frequencies determined with normal (2 mM Ca^2+^) and 5 mM Ca^2+^ Krebs in the presence of 2 mM caffeine. **C.** Caffeine-induced Ca2+ oscillations by monitoring ER Ca2+. ER \[Ca^2+^\]~ER~ levels in normal and 5 mM Ca^2+^ Krebs solution with 2 mM caffeine. For WT and R615C, upper levels during Ca^2+^ oscillations (threshold levels for Ca^2+^ release) were measured.](pone.0130606.g003){#pone.0130606.g003}

The other 10 mutants, however, rarely showed Ca^2+^ oscillations; instead, they exhibited the constant \[Ca^2+^\]~ER~ level during the observations (see [Fig 3A](#pone.0130606.g003){ref-type="fig"}, C36R and G249R). The \[Ca^2+^\]~ER~ levels of C36R and G249R were higher and lower than that for R615C, respectively, suggesting no correlation between Ca^2+^ oscillations and \[Ca^2+^\]~ER~ level in the MH mutants ([Fig 3C](#pone.0130606.g003){ref-type="fig"}). Increase in extracellular Ca^2+^ (\[Ca^2+^\]~o~) from 2 mM to 5 mM did not induce Ca^2+^ oscillations ([Fig 3B](#pone.0130606.g003){ref-type="fig"}) nor significantly affect the \[Ca^2+^\]~ER~ level ([Fig 3C](#pone.0130606.g003){ref-type="fig"}). To summarize, high propensity for spontaneous Ca^2+^ oscillation was not a common characteristic of all MH mutations.

Determination of the activity profiles by \[^3^H\]ryanodine binding and parameter analysis {#sec017}
------------------------------------------------------------------------------------------

To quantitatively evaluate the activity of mutant RyR1 channels, we determined Ca^2+^-dependent \[^3^H\]ryanodine binding using microsomes isolated from HEK293 cells. Since ryanodine specifically binds to the open channel, \[^3^H\]ryanodine binding is a useful measure for functional state of the RyR channel \[[@pone.0130606.ref033]--[@pone.0130606.ref035]\]. The \[^3^H\]ryanodine binding value at the specified \[Ca^2+^\] was expressed as *B*/*B* ~max~, which represents the ratio of active to total channels under the conditions employed \[[@pone.0130606.ref008]\]. WT exhibited biphasic Ca^2+^-dependent \[^3^H\]ryanodine binding with the peak near 30 μM Ca^2+^ ([Fig 4A](#pone.0130606.g004){ref-type="fig"}). The peak *B*/*B* ~max~ value was ≈0.03, which is consistent with RyR1 from skeletal muscle \[[@pone.0130606.ref036], [@pone.0130606.ref037]\]. All the disease-associated mutants showed greater binding than WT (Fig [4A](#pone.0130606.g004){ref-type="fig"}--[4D](#pone.0130606.g004){ref-type="fig"}). To our surprise, there was a large variation in Ca^2+^-dependent curves between mutants.

![Ca^2+^-dependent \[^3^H\]ryanodine binding of WT and mutant RyR1s.\
**A--D.** Ca^2+^-dependent \[^3^H\]ryanodine binding was determined at 25°C in 0.17 M NaCl, 20 mM MOPSO, pH 6.8, 2 mM dithiothreitol, 1 mM AMP and various concentrations of Ca^2+^ buffered with 10 mM EGTA. Curves without data points in **B--D** indicate WT. Data are means ± SE (*n* = 3--5). Note that the mutants show greater \[^3^H\]ryanodine binding than WT. **E--H.** Activity profiles of the mutant channels. The three parameters, *A* ~max~, *K* ~A~ and *K* ~I~, were obtained by fitting analysis (see [Materials and Methods](#sec002){ref-type="sec"}) and plotted on the radar charts relative to WT. 1/*K* ~A~ was used as the parameter for activating Ca^2+^ dissociation constants, in which a larger value represents higher sensitivity. Note that the size of the triangle represents the magnitude of the channel activity.](pone.0130606.g004){#pone.0130606.g004}

The results of the \[^3^H\]ryanodine binding were fitted to eqs [(1)](#pone.0130606.e001){ref-type="disp-formula"})--[(3)](#pone.0130606.e003){ref-type="disp-formula"} to obtain the three parameters, i.e., the gain (*A* ~max~) and dissociation constants for activating Ca^2+^ (*K* ~A~) and inactivating Ca^2+^ (*K* ~I~) ([S1 Fig](#pone.0130606.s001){ref-type="supplementary-material"}). The obtained parameters are summarized in [S1 Table](#pone.0130606.s003){ref-type="supplementary-material"}. *A* ~max~ increased (1.6--10.8-fold) for all the mutations relative to the WT channel. The *K* ~A~ greatly decreased (0.08--0.18-fold) in two MH/CCD mutations (R164C and Y523S) and three MH mutations (R164L, G342R and Y523C) when compared with the results of the WT, whereas moderate decreases (0.31--0.57-fold) in *K* ~A~ were observed for the other MH mutations, except for R615C. The *K* ~I~ increased (1.5--2.8-fold) in four mutants (R164C, Y523C, Y523S and R164L) when compared with the results of the WT, but no significant change in the other mutants was observed.

Activity profiles of mutant channels were visualized by radar charts, in which the three parameters were plotted relative to WT (Fig [4E](#pone.0130606.g004){ref-type="fig"}--[4H](#pone.0130606.g004){ref-type="fig"}). 1/*K* ~A~ was used as the parameter for sensitivity to activating Ca^2+^, in which a larger value represents higher sensitivity. The size of the triangle represents the magnitude of the activity. We found that two triangles for mutations at the same sites were similar in shape. In R615C and R615L, the increase in *A* ~max~ was more marked when compared with 1/*K* ~A~ and *K* ~I~ ([Fig 4E](#pone.0130606.g004){ref-type="fig"}). Similar properties were also observed with R402C, R402H and G249R ([Fig 4F](#pone.0130606.g004){ref-type="fig"}). Mutations at R164 (R164C and R164L) and C36 (C36R), in contrast, exhibited more marked enhancement in 1/*K* ~A~ compared with *A* ~max~ and *K* ~I~ ([Fig 4G](#pone.0130606.g004){ref-type="fig"}). In G342R, Y523C and Y523S, all three parameters were greatly increased ([Fig 4H](#pone.0130606.g004){ref-type="fig"}). These findings strongly suggest site-specific effects of the mutations on the activity profiles. The two MH/CCD mutants, R164C and Y523S, both exhibited a marked increase in 1/*K* ~A~. Interestingly, some MH mutants (R164L, G342R and Y523C) showed activity profiles similar to the MH/CCD mutants (Fig [4G](#pone.0130606.g004){ref-type="fig"} and [4H](#pone.0130606.g004){ref-type="fig"}).

Estimation of the activity of mutant channels at resting \[Ca^2+^\]~i~ {#sec018}
----------------------------------------------------------------------

To consider the pathological phenotype by specific mutations, it is critically important to obtain quantitative information about the activity of the mutant channel at resting \[Ca^2+^\]~i~. However, \[^3^H\]ryanodine binding over the resting \[Ca^2+^\]~i~ range was too low to be accurately determined (see [Fig 4](#pone.0130606.g004){ref-type="fig"}). Instead, we estimated the ryanodine binding of the mutant channel at pCa 7 using the three parameters (*K* ~A~, *K* ~I~ and *A* ~max~) listed in [S1 Table](#pone.0130606.s003){ref-type="supplementary-material"} (see [Materials and Methods](#sec002){ref-type="sec"}). Binding was significantly higher than WT with large variability (4--100-fold increase) ([Fig 5A](#pone.0130606.g005){ref-type="fig"}). The rank order was as follows: WT \< R615C \< C36R \< R402H ≈ R402C \< G249R \< R615L ≈ R164C \< G342R \< R164L \< Y523C \< Y523S. To test the validity of these values, we compared the estimated \[^3^H\]ryanodine binding with the \[Ca^2+^\]~ER~ of HEK293 cells, which reflects Ca^2+^ leakage via Ca^2+^ release. A good inverse correlation between the two was observed ([Fig 5B](#pone.0130606.g005){ref-type="fig"}).

![Estimation of the activity of mutant channels at resting \[Ca^2+^\]~i~.\
**A.** Ryanodine binding of mutant channels under resting conditions (pCa 7) was estimated by substituting the three parameters (*K* ~A~ and *K* ~I~ and *A* ~max~) into eqs [(1)](#pone.0130606.e001){ref-type="disp-formula"}--[(3)](#pone.0130606.e003){ref-type="disp-formula"} and plotted relative to WT in ascending order. **B.** \[Ca^2+^\]~ER~ for WT (filled circle), MH mutations (open circles) and MH/CCD mutations (crosses) were plotted against their estimated ryanodine binding at pCa 7.](pone.0130606.g005){#pone.0130606.g005}

Effects of temperature on the properties of the mutant channels {#sec019}
---------------------------------------------------------------

The recent crystallographic study of the N-terminal domain of RyR1 has shown that several mutations, including C36R, significantly decrease the melting point from 47°C for the WT to \~40°C (37.7°C for C36R) \[[@pone.0130606.ref038]\]. It is hypothesized that these mutations may destabilize the channel at the temperature of the body, but not at RT. We therefore investigated the properties of the mutant channels at higher temperatures (36--37°C).

We initially determined the Ca^2+^-dependent \[^3^H\]ryanodine binding of WT and mutant channels. Since the rate of \[^3^H\]ryanodine binding at 37°C was faster than at 25°C \[[@pone.0130606.ref039], [@pone.0130606.ref040]\], the incubation period was shortened to 3 h. Therefore, *B*/*B* ~max~ values obtained at 37°C cannot be directly compared with those at 25°C. All the mutants showed greater binding than the WT and some mutants exhibited higher sensitivity to Ca^2+^ for activation at 37°C ([Fig 6](#pone.0130606.g006){ref-type="fig"} and [S1 Table](#pone.0130606.s003){ref-type="supplementary-material"}). The effect of temperature on the activity profiles was examined by comparing the three parameters (*A* ~max~, *K* ~A~, and *K* ~I~) for each mutant at 25 and 37°C (Fig [7A](#pone.0130606.g007){ref-type="fig"}--[7C](#pone.0130606.g007){ref-type="fig"}). High linear correlations (*R* ^2^ \> 0.8) were obtained between the mutants for the three parameters and no specific effects on C36R were detected. A good correlation was also observed for the estimated ryanodine binding at pCa 7 with the obtained parameters ([Fig 7D](#pone.0130606.g007){ref-type="fig"}). These findings indicate that temperature dependence of the activity profiles are similar between the N-terminal mutations examined.

![Ca^2+^-dependent \[^3^H\]ryanodine binding of WT and mutant RyR1s at 37°C.\
**A--D.** Ca^2+^-dependent \[^3^H\]ryanodine binding was determined as in [Fig 4](#pone.0130606.g004){ref-type="fig"} at 37°C instead of RT. Curves without data points in **B--D** indicate WT. Data are means ± SE (*n* = 3--5). **E--H.** Activity profiles of the mutant channels.](pone.0130606.g006){#pone.0130606.g006}

![Comparison of the activity profiles between 25 and 37°C.\
The three parameters, *A* ~max~ (**A**), *K* ~A~ (**B**) and *K* ~I~, (**C**) for WT (filled circles), MH (open circles), MH/CCD (crosses) and C36R (triangles) at 25 and 37°C are plotted. Note that high linear correlations (*R* ^2^ \> 0.8) were found between mutants for all parameters. **D.** Estimated ryanodine binding at pCa 7.](pone.0130606.g007){#pone.0130606.g007}

We next measured ER Ca^2+^ of HEK293 cells expressing mutant channels at 36°C. The ER Ca^2+^ level was reduced by varying amounts for the mutants when compared with the results of the WT ([Fig 8A](#pone.0130606.g008){ref-type="fig"}). C36R, which exhibited no significant change in ER Ca^2+^ at RT (see [Fig 2](#pone.0130606.g002){ref-type="fig"}), showed a significant decrease of ER Ca^2+^ at 36°C. The ER Ca^2+^ correlated well with the estimated ryanodine binding at pCa 7 at 37°C ([Fig 8B](#pone.0130606.g008){ref-type="fig"}). Linear correlations were obtained between ER Ca^2+^ at 36°C and RT. ([Fig 8C](#pone.0130606.g008){ref-type="fig"}), indicating that the severity order in terms of store depletion was similar between data measured at RT and 37°C. However, it is noteworthy that ER Ca^2+^ levels relative to WT was lower at 36°C than at RT for most mutants.

![Cellular Ca^2+^ homeostasis of cells expressing WT or mutant RyR1s at 36°C.\
**A.** \[Ca^2+^\]~ER~ of WT (filled column), MH mutations (open columns) and MH/CCD mutations (hatched columns). Data are means ± SE (*n* = 30--67). \**p* \< 0.05 compared with WT. **B.** \[Ca^2+^\]~ER~ for WT (filled circle), MH (open circles) and MH/CCD (crosses) were plotted against their estimated ryanodine binding at pCa 7 at 37°C. **C.** ER Ca^2+^ for MH (open circles) and MH/CCD (crosses) relative to WT (filled circle) at RT and 36°C was plotted. The dotted line represents y = x equation. Therefore, mutants under the line indicate that their ER Ca^2+^ relative to WT is lower at 36°C than at RT. **D.** Caffeine-induced Ca^2+^ transients of WT (open circles), C36R (open triangles) and R615C (filled circles) at 36°C. Note that caffeine sensitivity for C36R was not increased, whereas R615C exhibited a marked enhancement in caffeine sensitivity.](pone.0130606.g008){#pone.0130606.g008}

Since C36R exhibited no significant changes in caffeine sensitivity at RT (see [Fig 1](#pone.0130606.g001){ref-type="fig"}), we tested caffeine dependence of this mutant at 36°C. No increase in the caffeine sensitivity was observed ([Fig 8D](#pone.0130606.g008){ref-type="fig"}). In contrast, R615C, which showed a similar ER Ca^2+^ to C36R ([Fig 8A](#pone.0130606.g008){ref-type="fig"}), exhibited a marked increase in caffeine sensitivity at 36°C.

Discussion {#sec020}
==========

Characteristics of disease-associated mutations in the RyR1 channel have been evaluated using a number of methods. Assays for clinical practice, incorporating enhanced sensitivity to caffeine or halothane, for example the caffeine/halothane contracture test, have been used to detect MH using fresh biopsied muscles \[[@pone.0130606.ref013], [@pone.0130606.ref041]--[@pone.0130606.ref043]\]. However, comparison among various mutants is difficult with this method because data can be confounded by many factors, including gender and size of muscle preparations \[[@pone.0130606.ref013]\]. Heterologous expression systems with non-muscle \[[@pone.0130606.ref020], [@pone.0130606.ref030], [@pone.0130606.ref031]\] or muscle cells \[[@pone.0130606.ref014], [@pone.0130606.ref015], [@pone.0130606.ref044]\] allow the exploration of RyR1 mutants under the same conditions. These studies revealed different Ca^2+^ homeostasis between MH and MH/CCD mutations. However, the question of how the disease-associated mutations affect activity profiles of the RyR1 channel remains unanswered.

In this study, we generated HEK293 cells stably expressing 11 disease-associated mutations at 7 different positions in the N-terminal region. Pathological phenotype of the mutations were examined by cellular Ca^2+^ homeostasis and the activity profiles were determined using \[^3^H\]ryanodine binding and parameter analysis. The activity profiles are constituted by three parameters: Ca^2+^ sensitivities for activation (*K* ~A~) and for inactivation (*K* ~I~) and the gain (*A* ~max~), an attainable maximum activity. We found that (1) the disease associated mutations affected *A* ~max~ and *K* ~A~ to varying extents in a site-specific manner, (2) channel activity at resting \[Ca^2+^\]~i~ estimated from the obtained parameters was highly variable among mutations, (3) the channel activity at resting \[Ca^2+^\]~i~ correlated well with \[Ca^2+^\]~ER~, and (4) temperature dependences of cellular Ca^2+^ homeostasis and activity profiles were similar between mutations. These results suggest that the disease-associated mutations in the N-terminal region divergently affect the activity profiles of the RyR1 channel to cause different disease phenotypes.

Measurement of cellular Ca^2+^ homeostasis {#sec021}
------------------------------------------

Sensitivity to caffeine in caffeine-induced Ca^2+^ transients is a useful measure to detect MH. Caffeine makes RyR1 sensitive to activating Ca^2+^ \[[@pone.0130606.ref001], [@pone.0130606.ref002]\]. This triggers regenerative Ca^2+^ release, where Ca^2+^ released from the ER activates the channel \[[@pone.0130606.ref006], [@pone.0130606.ref007]\]. Most disease-associated mutations exhibited an enhanced sensitivity to caffeine ([Fig 1](#pone.0130606.g001){ref-type="fig"}). However, Y523C and Y523S showed unchanged and decreased sensitivities, respectively. Because the two mutants exhibited severe depletion of \[Ca^2+^\]~ER~ ([Fig 2](#pone.0130606.g002){ref-type="fig"}), the regenerative process would be weakened, leading to an apparent reduction in caffeine sensitivity. This may also explain why mutants with different channel activities showed similar EC~50~ values. Quantitative evaluation of caffeine sensitivity should be interpreted with caution in regard to \[Ca^2+^\]~ER~.

In the analysis of cellular Ca^2+^ homeostasis, \[Ca^2+^\]~ER~ is a good index for Ca^2+^ leakage, which is related to channel activity. \[Ca^2+^\]~ER~ for the disease-associated mutations has been estimated indirectly by measuring \[Ca^2+^\]~i~ upon stimulation with an agonist (e.g., carbachol or ATP) or after treatment with Ca^2+^-pump inhibitors (e.g., cyclopiazonic acid or thapsigargin) \[[@pone.0130606.ref014], [@pone.0130606.ref015], [@pone.0130606.ref031]\]. However, quantitative measurements were difficult in these studies because of the nonlinear relationship between \[Ca^2+^\]~ER~ and \[Ca^2+^\]~i~. Therefore, we directly measured \[Ca^2+^\]~ER~ using a novel genetically-encoded fluorescent Ca^2+^ indicator, R-CEPIA1er \[[@pone.0130606.ref024]\] ([Fig 2](#pone.0130606.g002){ref-type="fig"}). Quantitative measurements revealed a good correlation between \[Ca^2+^\]~ER~ and \[^3^H\]ryanodine binding at resting Ca^2+^ ([Fig 5](#pone.0130606.g005){ref-type="fig"}). \[Ca^2+^\]~ER~ is, thus, a useful measure for evaluating the activity of the RyR1 channel with disease-associated mutations.

We found that resting \[Ca^2+^\]~i~ is increased in cells expressing mutant channels ([Fig 1](#pone.0130606.g001){ref-type="fig"}). This is consistent with previous studies with heterologous expression systems \[[@pone.0130606.ref014], [@pone.0130606.ref030], [@pone.0130606.ref031], [@pone.0130606.ref045], [@pone.0130606.ref046]\] and knock-in mice \[[@pone.0130606.ref027], [@pone.0130606.ref039], [@pone.0130606.ref040], [@pone.0130606.ref047]\]. The \[Ca^2+^\]~i~ level is determined by a balance between influx and efflux of Ca^2+^ across the plasma membrane \[[@pone.0130606.ref048]\]. Recent studies demonstrated that store-operated Ca^2+^ entry (SOCE) pathway is accelerated in muscle cells from knock-in mice carrying R163C \[[@pone.0130606.ref049]\] and Y524S \[[@pone.0130606.ref050]\] mutations. SOCE pathway may also be involved in increase in resting \[Ca^2+^\]~i~ in HEK cell expressing RyR1 mutants.

Properties of individual MH and MH/CCD mutations {#sec022}
------------------------------------------------

Functional characterizations have been done for most mutations using a heterologous expression system (References in [Table 1](#pone.0130606.t001){ref-type="table"}) or knock-in mice \[[@pone.0130606.ref027], [@pone.0130606.ref039], [@pone.0130606.ref040], [@pone.0130606.ref047], [@pone.0130606.ref051], [@pone.0130606.ref052]\]. The results of the present study combined with the previous reports provide information about properties of individual MH and MH/CCD mutations and explanation for different phenotypes between the mutations.

C36R exhibited small but significant \[Ca^2+^\]~ER~ depletion at 36°C, whereas it did not show any \[Ca^2+^\]~ER~ depletion at RT. The mutant channel exhibited small increase in the gain (*A* ~max~) and the sensitivity to activating Ca^2+^ (1/*K* ~A~), indicating a weak phenotype. Weak phenotype was suggested from the results with HEK293 cells \[[@pone.0130606.ref020], [@pone.0130606.ref031]\] and the presence of homozygous patients with the corresponding mutation \[[@pone.0130606.ref053]\]. We could not detect an enhanced caffeine sensitivity at RT nor 36°C, which was in contrast to the previous studies \[[@pone.0130606.ref020], [@pone.0130606.ref053]\]. It remains so far unclear about the reason for the difference.

R164C exhibited enhanced caffeine sensitivity with an increase in \[Ca^2+^\]~i~ and a depletion in \[Ca^2+^\]~ER~. This is consistent with previous studies with heterologous expression systems \[[@pone.0130606.ref014], [@pone.0130606.ref020], [@pone.0130606.ref031], [@pone.0130606.ref044]--[@pone.0130606.ref046]\] and knock-in mice carrying the corresponding mutation \[[@pone.0130606.ref027], [@pone.0130606.ref040]\]. R164L showed similar phenotypes. These mutations greatly enhanced the sensitivity to activating Ca^2+^ with a moderate increase in the gain, causing a large enhancement in channel activity.

G249R and G342R are located in the same domain \[[@pone.0130606.ref026]\]. The cellular Ca^2+^ homeostasis was more severely affected by G342R than by G249R. This difference was not clear in previous reports that compared the two mutations \[[@pone.0130606.ref020], [@pone.0130606.ref031]\]. The two mutations showed similar gain, but G342R exhibited a more enhanced sensitivity to activating Ca^2+^ than G249R. This may cause a more severe phenotype for G342R than for G249R.

R402C and R402H showed enhanced caffeine sensitivity with a moderate increase in \[Ca^2+^\]~i~ and a decrease in \[Ca^2+^\]~ER~. This is the first report to examine caffeine sensitivity and cellular \[Ca^2+^\] measurements for these mutations, although sensitivity to 4-chloro-m-cresol has been performed for R402C with HEK293 cells \[[@pone.0130606.ref054]\]. These mutations increased the gain with a moderate increase in the sensitivity to activating Ca^2+^.

Y523S exhibited the most severe phenotype in this study, which caused marked depletion in \[Ca^2+^\]~ER~ and an increase in \[Ca^2+^\]~i~. These properties are consistent with the previous findings with heterologous expression systems \[[@pone.0130606.ref014], [@pone.0130606.ref030], [@pone.0130606.ref031]\] and with knock-in mice carrying the corresponding mutation \[[@pone.0130606.ref039], [@pone.0130606.ref047], [@pone.0130606.ref051], [@pone.0130606.ref052]\]. Y523C, which has not been characterized so far, showed a similar phenotype. These mutations markedly increased both the gain and the sensitivity to activating Ca^2+^. We found that Y523S exhibited a more severe phenotype than R164C (Figs [1](#pone.0130606.g001){ref-type="fig"} and [2](#pone.0130606.g002){ref-type="fig"}). This was also shown by the previous studies \[[@pone.0130606.ref014], [@pone.0130606.ref031]\]. The difference may be explained by the greater increase in the gain in Y523S. It would be interesting to address whether Y524S knock-in mice exhibits more severe phenotype than R163C knock-in mice.

R615C showed enhanced caffeine sensitivity, but no or only slight changes in \[Ca^2+^\]~i~ and \[Ca^2+^\]~ER~. This corresponds to previous reports with heterologous expression systems \[[@pone.0130606.ref015], [@pone.0130606.ref020], [@pone.0130606.ref030], [@pone.0130606.ref031]\]. This mutation greatly accelerated the gain with only slight effects on the Ca^2+^ sensitivity, consistent with the results with MH pigs carrying the corresponding mutation \[[@pone.0130606.ref055]\]. R615L showed a more severe phenotype than R615C, which is consistent with the results with biopsied muscles \[[@pone.0130606.ref056]\] or HEK293 cells \[[@pone.0130606.ref020], [@pone.0130606.ref031]\]. The greater increased gain and sensitivity to activating Ca^2+^ for R615L may explain the difference.

Overall, the results of the present study are consistent with previous findings and the activity profiles reasonably explain the differences in phenotypes among mutations. An increase in the gain is a common feature for all the mutations. The gain is important in the pathogenesis of the MH phenotype. In contrast, MH/CCD mutations exhibited a marked increase in sensitivity to activating Ca^2+^. An increased sensitivity to activating Ca^2+^ further accelerates channel activity to exceed the threshold for CICR to trigger Ca^2+^ leakage from Ca^2+^ stores under resting conditions.

Effects of temperature on cellular Ca^2+^ homeostasis and activity profiles {#sec023}
---------------------------------------------------------------------------

It has been hypothesized that some specific mutations, especially C36R, may destabilize the channel in a temperature-dependent manner and at temperatures close to 37°C. This is based on the finding that melting points for the N-terminal domain of several mutant RyR1s was significantly reduced \[[@pone.0130606.ref038]\]. However, the temperature dependence on activity profiles was similar among the mutants and no specific effects were observed for C36R or other mutants ([Fig 7](#pone.0130606.g007){ref-type="fig"}). Our data may not support the above hypothesis at least for the mutations examined in this study.

The heterozygous knock-in mice for MH/CCD demonstrate heat-induced muscle contracture and sudden death \[[@pone.0130606.ref027], [@pone.0130606.ref028]\]. Heat-induced activation of the mutant RyR1 channel is proposed to cause Ca^2+^ release from the SR under resting conditions \[[@pone.0130606.ref039], [@pone.0130606.ref040], [@pone.0130606.ref047]\]. ER Ca^2+^ relative to WT was lower at 36°C than at RT for most mutants, indicating an increase in Ca^2+^ leakage from the ER ([Fig 8](#pone.0130606.g008){ref-type="fig"}). Heat-induced activation may be a common characteristic of the N-terminal RyR1 mutants examined.

Physiological and pathological significance {#sec024}
-------------------------------------------

The combination of \[^3^H\]ryanodine binding and parameter analysis provided a relative rank order of the activity of the mutant channels. The rank order may predict risk and severity of the diseases. This is highly helpful for diagnosis of the diseases using genetic analysis. Interestingly, three MH mutations (R164L, G342R and Y523C) exhibited a high channel activity and severe depletion of \[Ca^2+^\]~ER~, which is comparable to that seen for MH/CCD mutations (R164C and Y523S) ([Fig 5](#pone.0130606.g005){ref-type="fig"}). It is expected that these mutations may also show signs of MH/CCD. Further evaluation of the muscle phenotype in patients with these mutations would be particularly interesting.

The activity profiles also provide useful information about treatment of the diseases. Currently, there is no specific treatment for CCD. An enhanced sensitivity to activating Ca^2+^ greatly contributes to Ca^2+^ leakage from Ca^2+^ stores in MH/CCD mutations (Figs [4](#pone.0130606.g004){ref-type="fig"} and [5](#pone.0130606.g005){ref-type="fig"}). Certain drugs that decrease the sensitivity to activating Ca^2+^ may inhibit Ca^2+^ leakage and thus represent a potential candidate for treatment of CCD.

A recent crystal structure of RyR1 has revealed that many mutations are located on the domain-domain interfaces at the N-terminal region \[[@pone.0130606.ref026], [@pone.0130606.ref038]\]. However it remains unclear how postulated alterations in inter-domain interaction cause acceleration of channel activity or increase in Ca^2+^ sensitivity. The activity profiles of the mutant channels would provide important information about structure-function relationships of the disease-associated mutations of the RyR1 channel.

It has been proposed that a reduced threshold level of \[Ca^2+^\]~ER~ for spontaneous Ca^2+^ release underlies a causal mechanism of MH carrying the R615C mutation \[[@pone.0130606.ref032]\]. We confirmed their finding that R615C reduced the threshold for caffeine-induced Ca^2+^ oscillations compared with WT ([Fig 4](#pone.0130606.g004){ref-type="fig"}). However, other mutants did not show caffeine-induced Ca^2+^ oscillations. Thus, occurrence of Ca^2+^ oscillations may not be a common characteristic for the MH and MH/CCD mutations. Further investigations will address possible contribution of luminal Ca^2+^ regulation to the underlying mechanism of MH and MH/CCD carrying the disease-associated mutations other than R615C.

Limitations and future research {#sec025}
-------------------------------

In skeletal muscle, the activity of RyR1 is controlled by DHPR and can be modulated by skeletal muscle-specific proteins \[[@pone.0130606.ref057], [@pone.0130606.ref058]\]. Since HEK293 cells lack such modulators, it can be argued that RyR1 expressed in HEK293 cells is somehow different from that in skeletal muscle cells. However, the three parameters, *A* ~max~, *K* ~A~ and *K* ~I~, for WT RyR1 channels were very similar to those of skeletal muscle \[[@pone.0130606.ref036], [@pone.0130606.ref037]\]. In addition, the activity profiles of R164C and R615C are in good agreement with those from animals carrying the same mutations (R163C knock-in mice \[[@pone.0130606.ref040]\] and MH pigs carrying R615C \[[@pone.0130606.ref055]\]). Thus, the channel activities of RyR1 mutants expressed in HEK293 cells are likely to reflect that in skeletal muscle.

Most human MH and CCD patients are heterozygous for WT and mutant alleles \[[@pone.0130606.ref009]\]. This is in contrast to our recombinant HEK293 cells that have only the mutant gene. It is reasonable to expect that the phenotype in our study is more severe compared with that seen in patients. In addition, properties of the heterotetrameric channels composed of WT and mutant subunits are, as yet, unclear. However, phenotype severity determined by a cell culture system \[[@pone.0130606.ref014], [@pone.0130606.ref015], [@pone.0130606.ref020], [@pone.0130606.ref030], [@pone.0130606.ref031], [@pone.0130606.ref044]\] corresponds to that of biopsied muscle from patients \[[@pone.0130606.ref013], [@pone.0130606.ref041]--[@pone.0130606.ref043]\]. The rank order of channel activity in this study is also consistent with that from patients. It is therefore expected that the properties of homotetrameric mutant channels are qualitatively similar to those of heterotetrameric channels.

Among the reported MH and MH/CCD mutations, many have been discovered in one or small numbers of families \[[@pone.0130606.ref009]\]. In such a situation, the effect of genetic background may be high and this makes it difficult to compare severity between mutations. The present approach, consisting of cellular Ca^2+^ homeostasis measurements and determination of activity profiles, provides useful information about phenotype and disease severity caused by individual mutations. Construction of a database for this information should aid diagnosis and predict prognosis of the diseases.

Supporting Information {#sec026}
======================

###### Simulation of Ca^2+^-dependent channel activity and activity profiles.

**A.** Ca^2+^-dependent channel activity (bold line) and fractions of A-site occupied by Ca^2+^ (*f* ~A~, thin line) and of I-site free from Ca^2+^ (1--*f* ~I~, dashed line) were simulated by eqs [(1)](#pone.0130606.e001){ref-type="disp-formula"}--[(3)](#pone.0130606.e003){ref-type="disp-formula"} using the following parameters: *A* ~max~ = 0.05, *K* ~A~ = 10 μM, *n* ~A~ = 1.2, *K* ~I~ = 0.15 mM, and *n* ~I~ = 1.5. **B.** Effect of individual parameters on channel activity. Parameters for the original curve (black line) are the same as those in **A.** Channel activity was simulated with either 4-fold decreased *K* ~A~ (*K* ~A~ = 2.5 μM, left), 4-fold increased *A* ~max~ (*A* ~max~ = 0.2, center), or 4-fold increased *K* ~I~ (*K* ~I~ = 0.6 mM, right). **C.** The activity profiles of WT and mutant channels in **B.** The three parameters, *A* ~max~, 1/*K* ~A~ and *K* ~I~, were plotted on the radar charts relative to WT. 1/*K* ~A~ was used as the parameter for activating Ca^2+^ dissociation constants, in which a larger value represents higher sensitivity.

(PDF)

###### 

Click here for additional data file.

###### Expression of mutant RyR1s in HEK293 cells.

Western blot analysis of RyR1 in microsomes from HEK293 cells expressing WT or disease-associated mutants. The mutant RyR1s showed gel mobility similar to that of the WT. Calnexin was used as a loading control.

(PDF)

###### 

Click here for additional data file.

###### Parameters for Ca^2+^-dependent \[^3^H\]ryanodine binding.

Data are mean ± SE (*n* = 3--5). Numbers in parentheses indicate fold change of the parameters relative to WT. \**P* \< 0.05 vs. WT.
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###### 

Click here for additional data file.
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